Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T12:55:15.398Z Has data issue: false hasContentIssue false

Multimaterial, heterogeneous, and multicellular three-dimensional bioprinting

Published online by Cambridge University Press:  10 August 2017

Carmelo De Maria
Affiliation:
Department of Ingegneria dell’Informazione and Research Center E. Piaggio, University of Pisa, Italy; carmelo.demaria@centropiaggio.unipi.it
Giovanni Vozzi
Affiliation:
Department of Ingegneria dell’Informazione and Research Center E. Piaggio, University of Pisa, Italy; g.vozzi@ing.unipi.it
Lorenzo Moroni
Affiliation:
MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, The Netherlands; l.moroni@maastrichtuniversity.nl

Abstract

Bioprinting promises to create three-dimensional in vitro models to study pathological states and possible new therapies, and in the future, to produce complex tissue and organ replacements. This article will describe the recent advances in bioprinting technologies to engineer artificial tissues and organs by controlling spatial heterogeneity of chemical and physical properties of scaffolds and, at the same time, the cellular composition and spatial arrangement. Despite significant technological improvements in recent years, the positioning at the micrometric level and the switching of different cell types and biomaterials remain a challenge, which limits the development of resilient vascular, neural, and lymphatic networks for metabolites, signaling, and waste transport, and thus limits the development of thick and clinically relevant engineered vascularized tissues.

Information

Type
Research Article
Copyright
Copyright © Materials Research Society 2017 
Figure 0

Table I. Influence of shear stress on cell viability during extrusion-based 3D printing, using a pneumatic system with a microvalve.46

Figure 1

Figure 1. Example of multicellular and vascularized scaffold, fabricated by combining a fugitive ink, a cell-laden ink, and a casting of a biomatrix. (a) Fabrication steps (i) Three-dimensional bioprinting of fugitive ink and cell-laden ink, (ii) casting of extracellular matrix material, (iii) removal of fugitive ink for creating the vascular network channels, and (iv) seeding of endothelial cells and perfusion of the vascular network. (b) Fabricated construct (fugitive [red] and cell-laden inks [green]; scale bar = 5 mm) and (c) confocal microscope image through a cross section of 1-cm-thick vascularized bone tissue construct after 30 days of active perfusion and in situ differentiation. Red: RFP-HUVECs, primary red fluorescent protein-expressing human umbilical vein endothelial cells; green, actin; violet, osteocalcin; blue, DAPI, 4′,6-diamidino-2-phenylindole. Scale bar = 1.5 mm. Adapted with permission from Reference 48. © 2016 National Academy of Sciences.

Figure 2

Figure 2. Example of multiscale and multimaterial scaffold fabricated using hybrid technologies. The 3DF region was built by extruding poly(ε-caprolactone) strands, while PLGA was electrospun on a specific location to fabricate a triphasic scaffold. (a) 3DF region (scale bar = 500 μm); (b) mixed region with electrospun PLGA over 3DF strands (scale bar = 200 μm); and (c) ESP region (scale bar = 20 μm).68 Note: 3DF, three-dimensional fiber deposition; ESP, electrospinning; PLGA, poly(lactic-co-glycolic acid).